Press Release: Sanofi and Regenerons Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria
Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the…
Travel Light, Travel Right: Spigens New Outdoor Essentials Are Here
Friday 8 August, 2025 Spigen, a global leader in tech accessories and…
